Author

Torsten Kucharzik

PROGNOSTIC VALUE OF INTESTINAL ULTRASOUND PARAMETERS FOR LONG-TERM OUTCOMES IN IBD PATIENTS – ONE YEAR INTERIM RESULTS OF THE TRUST BEYOND STUDY
PROGNOSTIC VALUE OF INTESTINAL ULTRASOUND PARAMETERS FOR LONG-TERM OUTCOMES IN IBD PATIENTS – ONE YEAR INTERIM RESULTS OF THE TRUST BEYOND STUDY

INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL REMISSION AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN'S DISEASE: STARDUST TRIAL SUBSTUDY RESULTS BY LINE OF TREATMENT AND LOCATION
INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL REMISSION AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN'S DISEASE: STARDUST TRIAL SUBSTUDY RESULTS BY LINE OF TREATMENT AND LOCATION

Dynamic management of CD: reaching a new dimension in patient care (Janssen)
Dynamic management of CD: reaching a new dimension in patient care (Janssen)

Torsten Kucharzik  et al.

PROGNOSTIC VALUE OF INTESTINAL ULTRASOUND PARAMETERS FOR LONG-TERM OUTCOMES IN IBD PATIENTS – ONE YEAR INTERIM RESULTS OF THE TRUST BEYOND STUDY
PROGNOSTIC VALUE OF INTESTINAL ULTRASOUND PARAMETERS FOR LONG-TERM OUTCOMES IN IBD PATIENTS – ONE YEAR INTERIM RESULTS OF THE TRUST BEYOND STUDY

Torsten Kucharzik  et al.

INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL REMISSION AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN’S DISEASE: STARDUST TRIAL SUBSTUDY RESULTS BY LINE OF TREATMENT AND LOCATION
INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL REMISSION AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN’S DISEASE: STARDUST TRIAL SUBSTUDY RESULTS BY LINE OF TREATMENT AND LOCATION

Torsten Kucharzik  et al.

INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL HEALING AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN’S DISEASE: STARDUST TRIAL SUBSTUDY
INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL HEALING AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN’S DISEASE: STARDUST TRIAL SUBSTUDY

Torsten Kucharzik

IMPROVEMENT OF INTESTINAL ULTRASOUND PARAMETERS WITHIN 12 WEEKS AFTER TREATMENT INDUCTION IN CD AND UC PATIENTS - FIRST INTERIM ANALYSIS OF THE TRUST BEYOND STUDY
IMPROVEMENT OF INTESTINAL ULTRASOUND PARAMETERS WITHIN 12 WEEKS AFTER TREATMENT INDUCTION IN CD AND UC PATIENTS - FIRST INTERIM ANALYSIS OF THE TRUST BEYOND STUDY

Torsten Kucharzik  et al.

Exploring the evolution of care in Crohn’s disease (Janssen)
Exploring the evolution of care in Crohn’s disease (Janssen)

Torsten Kucharzik  et al.

ONE-YEAR INTESTINAL ULTRASOUND IMPROVEMENTS IN UC PATIENTS ON BIOLOGIC OR JAKI THERAPY – INTERIM RESULTS OF THE TRUST BEYOND STUDY
ONE-YEAR INTESTINAL ULTRASOUND IMPROVEMENTS IN UC PATIENTS ON BIOLOGIC OR JAKI THERAPY – INTERIM RESULTS OF THE TRUST BEYOND STUDY

Torsten Kucharzik  et al.

Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS)
Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS)

Torsten Kucharzik  et al.

INTESTINAL ULTRASOUND IN MONITORING POSTOPERATIVE CROHN´S DISEASE
INTESTINAL ULTRASOUND IN MONITORING POSTOPERATIVE CROHN´S DISEASE

Torsten Kucharzik  et al.

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Torsten Kucharzik  et al.

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment
ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Torsten Kucharzik  et al.

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

Torsten Kucharzik  et al.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Torsten Kucharzik  et al.

LONG-TERM EFFECTIVENESS OF DARVADSTROCEL IN PATIENTS WITH COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE: RESULTS FROM INSPECT, A RETROSPECTIVE CHART REVIEW STUDY IN EUROPE
LONG-TERM EFFECTIVENESS OF DARVADSTROCEL IN PATIENTS WITH COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE: RESULTS FROM INSPECT, A RETROSPECTIVE CHART REVIEW STUDY IN EUROPE

Torsten Kucharzik  et al.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Torsten Kucharzik  et al.

USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE
USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE

Torsten Kucharzik  et al.

Item 1 - 18 / 18
1